Last reviewed · How we verify
A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors
This study will assess the safety and efficacy of JZP341 in participants with advanced or metastatic solid tumors.
Details
| Lead sponsor | Jazz Pharmaceuticals |
|---|---|
| Phase | PHASE1 |
| Status | TERMINATED |
| Enrolment | 12 |
| Start date | Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Apr 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Advanced Solid Tumor
- Metastatic Solid Tumor
Interventions
- JZP341
Countries
United States